Stocksigma LogoStocksigma Logo

Q-Line Biotech Board to Consider Half-Year Financial Results on 12th Nov'26

Q-Line Biotech Limited has scheduled a Board of Directors meeting on 12th Nov'26 to consider and approve the unaudited standalone and consolidated

Q-Line Biotech Board to Consider Half-Year Financial Results on 12th Nov'26

Q-Line Biotech Ltd 路 Intimation 路 12 Nov 2026, 5:30 am

Q-Line Biotech Board to Consider Half-Year Financial Results on 12th Nov'26 Q-Line Biotech Limited has scheduled a Board of Directors meeting on 12th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the half year ended 30th Sep'26. The board will review the Statement of Assets and Liabilities, Cash Flow statement, and the Statutory Auditor's Limited Review Reports, pursuant to Regulation 29 of SEBI LODR Regulations.

Original exchange filing (PDF)

More announcements from Q-Line Biotech Ltd

All Q-Line Biotech Ltd announcements